top_banner
Cancer News

Recent Lung Cancer - Small Cell News
Opdivo® (nivolumab) Approved for Treatment of Small Cell Lung Cancer (August 23, 2018)

The U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for the treatment of metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and... Continue Reading

Precision Cancer Medicine PARP Inhibitor Promising Treatment for Small Cell Lung Cancer (June 25, 2018)

The results of a recent study published in The Journal of Clinical Oncology suggest the first new therapeutic option for Small Cell Lung Cancer (SCLC) in many years.  The study evaluated the addition... Continue Reading